White coat hypertension affected 65.2% of chronic kidney disease patients with uncontrolled clinic blood pressure and was significantly associated with diabetes (OR 4.92).
Does home blood pressure measurement compared to clinic measurement improve the detection of white coat hypertension in CKD patients with uncontrolled clinic BP?
White coat hypertension is highly prevalent (65.2%) in CKD patients with elevated clinic BP, highlighting the need for routine home BP monitoring for accurate diagnosis.
Absolute Event Rate: 0% vs 0%
Background Hypertension is common in chronic kidney disease (CKD), and white coat hypertension (WCH) complicates its diagnosis and treatment. Patients and methods We conducted a cross-sectional study of 66 CKD patients with uncontrolled clinic blood pressure (BP) at the nephrology outpatient clinic at Suez Canal University Hospital, comparing home and clinic BP readings to detect WCH. Results The mean clinic systolic BP (167.2 ± 13.7 mmHg) was significantly higher than the mean home systolic BP (131 ± 12.5 mmHg) ( P <0.005). WCH was identified in 65.2% of patients and was significantly associated with diabetes (odds ratio: 4.92; 95% confidence interval: 1.34–18.15). Conclusions WCH is highly prevalent, affecting nearly two-thirds of CKD patients with elevated clinic BP, highlighting the need for routine home BP monitoring for accurate diagnosis and individualized management.
Gawad et al. (Wed,) reported a other. White coat hypertension affected 65.2% of chronic kidney disease patients with uncontrolled clinic blood pressure and was significantly associated with diabetes (OR 4.92).